Jeremy Levin BY Poa Net Worth & Insider Trades
Jeremy Levin BY Poa - CEO, Ovid Therapeutics Inc
What is Jeremy Levin BY Poa's Net Worth?
The current estimated net worth of Ovid Therapeutics Inc's CEO, Jeremy Levin BY Poa, is estimated to be about $16.01M . Jeremy Levin BY Poa owns about 5,827,991 units of Ovid Therapeutics Inc common stock. In the last 4 years at Ovid Therapeutics Inc, Jeremy Levin BY Poa has sold an estimated value of $0 worth.
What is Jeremy Levin BY Poa's Past Insider Trading?
Jeremy Levin BY Poa's largest purchase order was 8,488 units , worth over $49.57K on September 1, 2020. In total, Jeremy Levin BY Poa has made about 6 transactions over 4 years of their time at Ovid Therapeutics Inc. Jeremy Levin BY Poa usually trades in February and December, with the busiest year in 2022 and 2020.
Jeremy Levin by PoA
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Jeremy Levin BY Poa's Salary in 2020?
As CEO of Ovid Therapeutics Inc, Jeremy Levin BY Poa has a total base salary of $560,000 . Jeremy Levin BY Poa received compensation valued at about $2,135,499 in 2020 after becoming CEO. The vast majority of their compensation came in the form of option awards of $1,274,260 , other earnings, plans or compensations of $280,000 , and other compensation of $21,239 .
Ovid Therapeutics Inc Executive Compensation
Name |
Year
|
Salary
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|
| Jeremy Levin, DPhil, MB BChir. | 2020 | $560,000 | $1,274,260 | $280,000 | $21,239 | $2,135,499 |
| Jeremy Levin, DPhil, MB BChir. | 2019 | $530,450 | $2,187,660 | $265,225 | $25,645 | $3,008,980 |
| Jeffrey Rona | 2020 | $107,860 | $1,710,293 | $170,000 | $922 | $1,989,075 |
| Thomas M. Perone, JD, MBA | 2020 | $440,000 | $842,145 | $176,000 | $17,371 | $1,475,516 |
| No matching records found | ||||||
Source: https://www.sec.gov/Archives/edgar/data/1636651/000156459021022189/ovid-def14a_20210610.htm
What are Ovid Therapeutics Inc's Past Insider Trades?
Ovid Therapeutics Inc's most recent insider trade came on September 14, 2022 by Jason Tardio who sold 17,344 units worth $37.29K . In the last 5 years, insiders at Ovid Therapeutics Inc have sold an estimated value of $163.49K and bought an estimated value of $5.64M worth of shares. Insider trading is most common in February, with the busiest year in 2019. The most active traders at the company are Jeremy Levin BY Poa, CEO, Karen Bernstein, Director, and Barbara Duncan BY Poa, Director .
Ovid Therapeutics Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||